MG

Participants took colchicine for at least six months, usually at doses of 0.5 mg once or twice daily.

Doctors generally recommend that people at high risk of a heart attack or stroke keep their LDL cholesterol less than 70 mg/dL, and those at very high risk keep it below 55 mg/dL.

In addition to significant weight reduction, those taking oral semaglutide 25 mg experienced improvements in daily physical function, including activities such as bending, walking, standing, and overall mobility, along with better cardiovascular risk profiles.

When the protein albumin was measured in the urine, the average level for participants was 714 mg/gm of creatinine; levels of 30 or higher may be a sign of chronic kidney disease.

In the trial, a European-sized dose of 100 mg aspirin was used.